Executive Summary The COVID-19 pandemic and subsequent global disruptions exposed critical vulnerabilities in pharmaceutical supply chains, particularly in low- and middle-income countries (LMICs). Heavy reliance on imports, limited local manufacturing capacity, weak regulatory systems, and fragmented distributiohealtghn networks contributed to stockouts of essential medicines and vaccines. This project aims to strengthen local pharmaceutical supply chains... [Read More]